0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

Post
Spotlight Jun 09

Featured Spotlight

Bundibugyo Ebola Outbreak Risk Assessment: International Spread, Countermeasure Gaps, and Global Coordination Recommendations

Analysis Briefing

All briefings

7-DAY ROUNDUP

Bundibugyo Ebola outbreak escalates with no vaccine; Africa CDC and WHO launch $518M response plan

  1. Use of Ebola Vaccines — Worldwide, 2021–2023 | MMWR - CDC (cdc.gov) | 17d ago
  2. Africa CDC: No Approved Vaccine for Ebola-Sudan Strain, Trial Underway (facebook.com) | 17d ago
  3. WHO R&D Blueprint Technical Advisory Group prioritizes therapeutics for Bundibugyo virus disease (iris.who.int) | 14d ago
  4. Development of Pandemic Vaccines: ERVEBO Case Study (pmc.ncbi.nlm.nih.gov) | 17d ago
  5. WHO Technical Advisory Group recommends BDBV-specific vaccines as preferred, considers Ervebo for post-exposure use in Bundibugyo outbreak (iris.who.int) | 15d ago
  6. CDC Clinical Guidance for Ebola Bundibugyo Virus: Outbreak Overview and Recommendations for Clinicians (May 2026) (cdc.gov) | 12d ago
  7. Ebola Virus Disease Vaccines – WHO Q&A (who.int) | 17d ago
  8. Evidence to Recommendations for rVSVΔG-ZEBOV-GP Ebola Vaccine (cdc.gov) | 17d ago
  9. rVSV-ZEBOV (Ervebo) Vaccine: Comprehensive Overview (en.wikipedia.org) | 14d ago
  10. WHO advises against routine use of Ervebo vaccine for Bundibugyo virus outbreak, recommends research rather than programmatic deployment (iris.who.int) | 12d ago
  11. Bundibugyo ebolavirus outbreak highlights spillover risks and vaccine gaps in western Uganda (news.mongabay.com) | 13d ago
  12. WHO Expert Groups Assess Candidate Treatments and Vaccines for Bundibugyo Virus Disease Outbreak in DRC and Uganda (who.int) | 12d ago
  13. WHO Technical Advisory Group prioritizes therapeutics for Bundibugyo virus disease (who.int) | 12d ago
  14. FDA approves Ebanga for Zaire ebolavirus treatment (fda.gov) | 1996d ago
  15. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of mAb114 (pmc.ncbi.nlm.nih.gov) | 17d ago
  16. WHO emergency guidance on licensed Ebola vaccine use during Bundibugyo virus disease outbreaks (who.int) | 12d ago
  17. WHO Technical Advisory Group Prioritizes Vaccine Candidates for Bundibugyo Virus Disease in DRC and Uganda (who.int) | 12d ago
  18. Ebola Vaccines Exist, But Not for Bundibugyo Strain in Current Uganda Outbreak (scientificamerican.com) | 17d ago
  19. Ervebo vaccine: EMA EPAR summary for EU authorization (ema.europa.eu) | 14d ago
  20. US CDC Issues Interim Final Rule to Suspend Entry of Persons from Ebola-Affected Countries (govinfo.gov) | 13d ago
  21. ERVEBO (Ebola Zaire Vaccine, Live) – Prescribing Information (merck.com) | 69d ago
  22. Ebola virus disease: an update on post-exposure prophylaxis – PMC (pmc.ncbi.nlm.nih.gov) | 14d ago
  23. Delayed FVM04/CA45 monoclonal antibody cocktail fully protects cynomolgus macaques against Sudan virus (journals.asm.org) | 14d ago
  24. Ebola outbreak in DR Congo: Reflections from West African survivor highlight need for speed, community trust, and vaccine development for Bundibugyo species (bbc.co.uk) | 18d ago
  25. MSF highlights diagnostic and treatment gaps in Bundibugyo virus outbreak in Uganda (doctorswithoutborders.org) | 14d ago
  26. Factbox: Bundibugyo Ebola vaccines and treatments in development (devdiscourse.com) | 18d ago
  27. CEPI's role in developing vaccines for epidemic-prone infectious diseases (law.berkeley.edu) | 15d ago
  28. No Vaccine: Managing the 2026 Bundibugyo Ebola Crisis (youtube.com) | just now
  29. FDA approves Ebanga (ansuvimab-zykl) for Zaire ebolavirus treatment (fda.gov) | 14d ago
  30. WHO selects maftivimab, remdesivir, and MBP134 as priority Ebola drugs for trials (pharmaphorum.com) | 11d ago
  31. Bundibugyo virus causing deadly Ebola outbreak in DRC and Uganda has no licensed vaccine (gavi.org) | 18d ago
  32. WHO reports 906 suspected Ebola cases, 223 deaths in DR Congo from Bundibugyo strain (indiatoday.in) | 11d ago
  33. No approved vaccine exists for Bundibugyo Ebola strain, impacting outbreak response (washingtonpost.com) | 19d ago
  34. Bundibugyo Ebola virus outbreak in DRC and Uganda: no approved countermeasures (wellcome.org) | 11d ago
  35. FDA Expands ERVEBO Approval to Children Aged 12 Months and Older (merck.com) | 14d ago
  36. Bundibugyo Ebola outbreak: A harsh reminder of the need for broad vaccine strategies (bioworld.com) | 19d ago
  37. Bundibugyo virus: Rare Ebola species with no approved vaccines or therapeutics (scientificamerican.com) | 18d ago
  38. Overview of experimental vaccines and treatments for Bundibugyo Ebola in DRC outbreak (cnbcafrica.com) | 11d ago
  39. US doctor infected with Ebola in DR Congo treated in Berlin (bbc.co.uk) | 22d ago
  40. WHO Issues Updated Guideline on Therapeutics for Ebola Virus Disease (iris.who.int) | 14d ago
  41. WHO recommends clinical trials for three experimental treatments for Bundibugyo Ebola strain (straitstimes.com) | 11d ago
  42. Review of Ebola Virus Outbreak Epidemiology and Treatment Advances (cureus.com) | 14d ago
  43. Bundibugyo virus outbreak in DR Congo: over 200 deaths, no approved vaccines or treatments (pbs.org) | 11d ago
  44. Ebanga™: The most recent FDA-approved drug for treating Ebola (pmc.ncbi.nlm.nih.gov) | 17d ago
  45. CDC Clinical Guidance for Ebola in Pregnant Women (cdc.gov) | 767d ago
  46. WHO reports 906 suspected Ebola cases and 223 deaths from Bundibugyo strain in DRC (indiatoday.in) | 11d ago
  47. Experimental treatments obeldesivir and MBP134 discussed for US Ebola patient with Bundibugyo virus (utmb.edu) | 11d ago
  48. MSF viewpoint proposes integrating monoclonal antibodies and vaccines as post-exposure prophylaxis for Ebola outbreak control (scienceportal.msf.org) | 15d ago
  49. Clinical Development of Ebola Vaccines (pmc.ncbi.nlm.nih.gov) | 17d ago
  50. Gavi allocates $50 million to Bundibugyo ebolavirus vaccine development and outbreak response (gavi.org) | 11d ago
Showing page 1 of 3 (106 total results)
← Prev Next →
src: all hn rss osint